Earnings release · CRL
Charles River Laboratories Announces Second-Quarter 2026 Results
Charles River Laboratories International, Inc. · Filed · SEC Form 8-K, Item 2.02
Charles River Laboratories International, Inc. company page Original on SEC.gov ↗
Why it matters
Revenue fell 2.7% year on year to $1.00 billion, and EPS declined 3.2% to $3.02. Sales and earnings both below a year ago call for a look at whether the decline is one-off or a trend. The company revised its guidance; the original release shows which items moved and by how much.
Written automatically by Stocknote's note engine from the figures on this page and the company's previous release. Every number in this note is checked against those figures. Not investment advice.
What the company states
$1.00 billion −2.7% vs a year ago
…Revenue was $1.00 billion, a decrease of 2.7% from $1.03 billion in the second quarter of 2025.…
$3.02 −3.2% vs a year ago
…Second-quarter diluted earnings per share on a non-GAAP basis were $3.02, a decrease of 3.2% from $3.12 per share in the second quarter of 2025.…
Guidance revised